Andrew E. Clark
Impact in
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- SARS-CoV-2 detection and testing 5
- Clostridium difficile and Clostridium perfringens research 5
- Epidemiology 11
- Infective Endocarditis Diagnosis and Management 4
- Co-authors
- Donna M. Wolk (6 shared papers)Erin Kaleta (3 shared papers)Amit Arora (1 shared paper)Michael Mallozzi (3 shared papers)V. K. Viswanathan (4 shared papers)Gayatri Vedantam (4 shared papers)Jacques Schrenzel (2 shared papers)Abdessalam Cherkaoui (2 shared papers)
- Journals
- Journal of Clinical Microbiology (6 papers)Clinical Chemistry (2 papers)Vaccines (2 papers)Microbiology Spectrum (2 papers)Frontiers in Microbiology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Andrew E. Clark
33 papers receiving 1.2k citations
Andrew E. Clark's Hit Papers
Peers
Comparison fields: 5 of 115
- Clinical Biochemistry 584
- Infectious Diseases 489
- Molecular Medicine 126
- Endocrinology 80
- Microbiology 11
Countries citing papers authored by Andrew E. Clark
This map shows the geographic impact of Andrew E. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Clark more than expected).
Fields of papers citing papers by Andrew E. Clark
This network shows the impact of papers produced by Andrew E. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Clark. The network helps show where Andrew E. Clark may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew E. Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology Hit paper breakdown → | 2013 | 614 |
| 2 | 2012 | 160 | |
| 3 | 2011 | 87 | |
| 4 | 2010 | 87 | |
| 5 | 2021 | 80 | |
| 6 | 2021 | 44 | |
| 7 | 2018 | 21 | |
| 8 | 2020 | 19 | |
| 9 | 2018 | 19 | |
| 10 | 2001 | 19 | |
| 11 | 2002 | 15 | |
| 12 | 2022 | 12 | |
| 13 | 2015 | 9 | |
| 14 | 2018 | 9 | |
| 15 | 2012 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2015 | 7 | |
| 18 | 2023 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2023 | 3 |
About Andrew E. Clark
Andrew E. Clark is a scholar working on Infectious Diseases, Epidemiology, Clinical Biochemistry, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Resistance in Bacteria (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), SARS-CoV-2 detection and testing (5 papers), Streptococcal Infections and Treatments (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Clinical Biochemistry (584 citations), Infectious Diseases (489 citations), Molecular Medicine (126 citations), Endocrinology (80 citations) and Microbiology (11 citations). Andrew E. Clark has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Donna M. Wolk, Erin Kaleta, Amit Arora, Michael Mallozzi, V. K. Viswanathan, Gayatri Vedantam, Jacques Schrenzel, Abdessalam Cherkaoui, Vicki H. Wysocki and Alagarraju Muthukumar. Their work appears in journals such as Journal of Clinical Microbiology, Clinical Chemistry, Vaccines, Microbiology Spectrum and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.